64 related articles for article (PubMed ID: 99363)
1. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
Suzuki Y; Nakamura N; Fukuoka K
Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
[TBL] [Abstract][Full Text] [Related]
2. Distribution of gangliosides, GM1 and GM3, in the rat oviduct.
Choo YK
Mol Cells; 1999 Feb; 9(1):56-60. PubMed ID: 10102572
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
Utz JR; Crutcher T; Schneider J; Sorgen P; Whitley CB
Mol Genet Metab; 2015 Feb; 114(2):274-80. PubMed ID: 25557439
[TBL] [Abstract][Full Text] [Related]
4. Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain.
Arthur JR; Heinecke KA; Seyfried TN
J Lipid Res; 2011 Jul; 52(7):1345-51. PubMed ID: 21508255
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside-magnetosome complex formation enhances uptake of gangliosides by cells.
Guan F; Li X; Guo J; Yang G; Li X
Int J Nanomedicine; 2015; 10():6919-30. PubMed ID: 26609230
[TBL] [Abstract][Full Text] [Related]
6. Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction.
Ceni C; Clemente F; Mangiavacchi F; Matassini C; Tonin R; Caciotti A; Feo F; Coviello D; Morrone A; Cardona F; Calamai M
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257371
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.
Larsson EA; Olsson U; Whitmore CD; Martins R; Tettamanti G; Schnaar RL; Dovichi NJ; Palcic MM; Hindsgaul O
Carbohydr Res; 2007 Feb; 342(3-4):482-9. PubMed ID: 17069778
[TBL] [Abstract][Full Text] [Related]
8. Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion.
Kwak DH; Kim SM; Lee DH; Kim JS; Kim SM; Lee SU; Jung KY; Seo BB; Choo YK
Mol Cells; 2005 Dec; 20(3):354-60. PubMed ID: 16404149
[TBL] [Abstract][Full Text] [Related]
9. Infantile gangliosidoses: Mapping a timeline of clinical changes.
Jarnes Utz JR; Kim S; King K; Ziegler R; Schema L; Redtree ES; Whitley CB
Mol Genet Metab; 2017 Jun; 121(2):170-179. PubMed ID: 28476546
[TBL] [Abstract][Full Text] [Related]
10. GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.
Chiricozzi E; Lunghi G; Di Biase E; Fazzari M; Sonnino S; Mauri L
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013258
[TBL] [Abstract][Full Text] [Related]
11. Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased
Percival BC; Latour YL; Tifft CJ; Grootveld M
Cells; 2021 Mar; 10(3):. PubMed ID: 33807817
[TBL] [Abstract][Full Text] [Related]
12. Process Engineering and Glycosyltransferase Improvement for Short Route Chemoenzymatic Total Synthesis of GM1 Gangliosides.
Yu H; Zhang L; Yang X; Bai Y; Chen X
Chemistry; 2023 May; 29(25):e202300005. PubMed ID: 36596720
[TBL] [Abstract][Full Text] [Related]
13. Asialo GM1 as a cell-surface marker in acute lymphoblastic leukemia.
Schwarting GA; Parkinson DR; Munson D; Zielinski C
N Engl J Med; 1981 Jan; 304(5):300-1. PubMed ID: 7003393
[No Abstract] [Full Text] [Related]
14. Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.
Fischetto R; Palladino V; Mancardi MM; Giacomini T; Palladino S; Gaeta A; Di Rocco M; Zampini L; Lassandro G; Favia V; Tripaldi ME; Strisciuglio P; Romano A; Severino M; Morrone A; Giordano P
Mol Genet Genomic Med; 2020 Oct; 8(10):e1371. PubMed ID: 32779865
[TBL] [Abstract][Full Text] [Related]
15. The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis.
Lang FM; Korner P; Harnett M; Karunakara A; Tifft CJ
Mol Genet Metab; 2020 Mar; 129(3):228-235. PubMed ID: 31937438
[TBL] [Abstract][Full Text] [Related]
16. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.
Osellame LD; Duchen MR
Br J Pharmacol; 2014 Apr; 171(8):1958-72. PubMed ID: 24116849
[TBL] [Abstract][Full Text] [Related]
17. In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.
Sinici I; Yonekawa S; Tkachyova I; Gray SJ; Samulski RJ; Wakarchuk W; Mark BL; Mahuran DJ
PLoS One; 2013; 8(3):e57908. PubMed ID: 23483939
[TBL] [Abstract][Full Text] [Related]
18. Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
Suzuki Y; Ogawa S; Sakakibara Y
Perspect Medicin Chem; 2009 May; 3():7-19. PubMed ID: 19812739
[TBL] [Abstract][Full Text] [Related]
19. GM1-Gangliosidosis: a molecular abnormality of acid beta-galactosidase in fibroblasts.
Furuya T; Suzuki Y
J Inherit Metab Dis; 1984; 7(3):145-6. PubMed ID: 6438402
[No Abstract] [Full Text] [Related]
20. Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.
Yoshida K; Oshima A; Shimmoto M; Fukuhara Y; Sakuraba H; Yanagisawa N; Suzuki Y
Am J Hum Genet; 1991 Aug; 49(2):435-42. PubMed ID: 1907800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
